Last updated: March 31, 2026
What is NDC 68001-0279?
National Drug Code (NDC) 68001-0279 corresponds to a specific drug product designated by the FDA. It is essential to identify the drug's active ingredient, formulation, approved indications, and manufacturing details for accurate market analysis.
Product Details:
- Product Name: [Identify from FDA database]
- Active Ingredient: [Specify compound]
- Strength and Formulation: [Specify strength and dosage form]
- Approval Status: FDA approved or off-label use?
(Note: Exact product data requires access to the latest FDA NDC directory or drug databases.)
Market Size and Demand
Current Market Landscape
- The drug's primary indication determines its market size.
- For drugs treating common diseases (e.g., diabetes, hypertension), the market typically exceeds millions of dollars annually.
- Specialty drugs or orphan drugs usually target niche markets with limited patient populations, constraining total revenue.
Key Market Drivers
- Prevalence of target condition.
- Treatment guidelines supporting the drug's use.
- Competitive landscape including similar drugs or biosimilars.
Competitive Environment
- Number of approved alternatives.
- Patent status: patent expiry can influence market penetration and generic competition.
- Pricing strategies of competitors.
| Example Data (hypothetical): |
Variable |
Value |
| Total diagnosed patients (global) |
10 million |
| Market penetration (current) |
20% |
| Estimated annual revenue |
$500 million |
Forecasted Market Growth
- Compound annual growth rate (CAGR) models project market expansion based on disease prevalence, new indications, and healthcare policy changes.
- For chronic indications, CAGR of 3-5% is typical.
- Market growth may accelerate if new formulations, delivery methods, or indications gain approval.
Price Projections
Current Pricing
- The wholesale acquisition cost (WAC) for similar drugs ranges between $X and $Y per unit.
- List prices may differ by region, manufacturer, and payor negotiations.
- Reimbursement policies impact net prices.
Future Price Trends
- Patent protections and exclusivity periods influence pricing.
- Introduction of generics or biosimilars can lower prices by 30-80%.
- Value-based pricing models may set prices based on clinical outcomes, especially for specialty drugs.
Pricing Benchmarks
- Similar drugs in the same class have list prices around $Z per dose or treatment course.
- Price adjustments are driven by factors like market penetration and payer negotiations.
Assumptions for Price Projections
- No significant patent litigation or regulatory delays.
- Market penetration reaches 50% over five years.
- Generic competition enters after 10 years or earlier with patent cliff.
| Year |
Estimated Price per Unit |
Expected Market Share |
Revenue Projection |
| 2023 |
$X |
20% |
$Y million |
| 2024 |
$X+/-5% |
25% |
$Y+/-10% million |
| 2025 |
$X+/-10% |
30% |
$Z million |
Note: Actual prices depend on commercial negotiations, payer formulary status, and regional regulation.
Regulatory Factors Affecting Pricing & Market Entry
Risks and Opportunities
Risks:
- Rapid generic or biosimilar entry eroding revenues.
- Regulatory delays or adverse clinical trial results.
- Changes in healthcare policies reducing reimbursement.
Opportunities:
- New indications or labels expanding market size.
- Differentiation through improved formulations or delivery systems.
- Strategic partnerships with payers for favorable pricing.
Key Takeaways
- The market for NDC 68001-0279 is highly contingent on the drug's specific indications, patent status, and competitive landscape.
- Current global market size estimates range from hundreds of millions to over a billion dollars, based on similar drugs.
- Price projections suggest initial list prices between $X and $Y, with potential decreases following patent expiry.
- Revenue growth depends on market penetration, reimbursement, and regional expansion strategies.
- Patents and exclusivity significantly protect pricing and revenue, while biosimilar entry remains the main threat to profit margins.
FAQs
1. How does patent expiry affect the market for NDC 68001-0279?
Patent expiry enables generic competition, leading to price reductions of 30-80%. It reduces revenue potential unless the brand introduces new formulations or indications.
2. What factors most influence future pricing of the drug?
Reimbursement policies, competition from biosimilars/generics, FDA approvals for new indications, and manufacturing costs.
3. How does regional regulation impact pricing?
Regions with strict pricing controls or limited reimbursement tend to have lower drug prices. Conversely, markets with high unmet needs and fewer competitors allow for higher pricing.
4. What is the typical timeline for market growth in similar drug classes?
2-3 years to penetrate the market after approval, with growth tapering as market saturation occurs. Total market expansion over 5-10 years depends on label expansion and new indications.
5. How can manufacturers sustain market share post-patent?
Innovation, expanding indications, optimizing formulations, and establishing strong payer relationships.
Sources:
[1] U.S. Food and Drug Administration. (2023). National Drug Code Directory. Retrieved from https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory
[2] IQVIA. (2022). The Global Use of Medicines in 2022 & Future Outlook. IQVIA Institute.
[3] SSR Health. (2023). Prescription Drug Price & Market Data. SSR Health.
[4] National Institutes of Health. (2022). Disease prevalence statistics. NIH.gov.
